Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Kidney Neoplasms × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 13 Ovarian Neoplasms 11 Neoplasms 7 Fallopian Tube Neoplasms 7 Pancreatic Neoplasms 6 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Prostatic Neoplasms 5 Endometrial Neoplasms 4 Neuroendocrine Tumors 3 Carcinoma, Ovarian Epithelial 3 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Glioma 2 Glioblastoma 2 Cholangiocarcinoma 2 Advanced Solid Tumor 2 Uveal Melanoma 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Tumor 1 Small Cell Lung Carcinoma 1 SCLC,Extensive Stage 1 Recurrent Ovarian High Grade Serous Adenocarcinoma 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Diseases 1 Platinum-sensitive Ovarian Cancer 1

Interventions

cabozantinib 7 pembrolizumab 5 Nivolumab 5 Radiosurgery 3 Ipilimumab 3 Axitinib 3 lenvatinib 2 Blood Specimen Collection 2 zimberelimab 1 tislelizumab 1 polyethylene glycol 3350 1 pazopanib 1 olaparib 1 gallium Ga 68 dotatate 1 brodalumab 1 belzutifan 1 anlotinib 1 adagrasib 1 Watchful Waiting 1 Vincristine 1 Ultrasonography 1 Temozolomide 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1 Radiotherapy 1 Radionuclide Imaging 1 Radiofrequency Ablation 1 Preoperative Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03786796 2025-03-13

ORCHID

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡